当前位置:主页 > 医学论文 > 中医论文 >

藏药抗肝癌活性研究

发布时间:2018-04-12 09:24

  本文选题:原发性肝癌 + 藏药 ; 参考:《华中师范大学学报(自然科学版)》2017年03期


【摘要】:本实验采用快速溶剂萃取法制备收集100种常用藏药的环己烷、乙酸乙酯和甲醇提取物,并运用MTT法对两个肝癌细胞株HepG2和SMMC-7721进行各提取物的抗肝癌活性测试,同时选用L-02细胞来评价其体外毒性.抗肝癌活性结果显示100种常用藏药中17种藏药材有良好的抗肝癌活性,其IC_(50)值均小于150μg/mL,其中马兜铃、蓝翠雀花、甘青青兰、掌叶橐吾的乙酸乙酯提取物显示出显著的抗肝癌活性,其IC_(50)值均小于50μg/mL,但马兜铃乙酸乙酯提取物对正常肝细胞L-02显示出一定的毒性.在进一步的抗HepG2肝癌活性验证中,结果显示蓝翠雀花乙酸乙酯提取物和甘青青兰乙酸乙酯提取物具有显著的抗肝癌活性,两者在抗HepG2肝癌细胞株活性中皆显示出显著的时效和量效关系.运用倒置显微镜以及Hoechst 33258荧光染色法对经过蓝翠雀花乙酸乙酯提取物或甘青青兰乙酸乙酯提取物作用的HepG2细胞形态进行观察,结果提示蓝翠雀花和甘青青兰乙酸乙酯提取物可能是通过诱导HepG2细胞凋亡而显示抗癌活性.
[Abstract]:The extraction of cyclohexane, ethyl acetate and methanol from 100 common Tibetan medicines was prepared by rapid solvent extraction. The antitumor activity of the extracts from two hepatoma cell lines, HepG2 and SMMC-7721, was tested by MTT method.At the same time, L-02 cells were selected to evaluate its toxicity in vitro.The results of anti-hepatocarcinoma activity showed that 17 of the 100 common Tibetan medicines had good anti-liver cancer activity, and their ICSP 50) values were less than 150 渭 g / mL, including Aristolochia spp.The ethyl acetate extract of Ligularia palliaria showed significant anti-hepatoma activity, and its ICL 50 value was less than 50 渭 g / mL, but the ethyl acetate extract from Aristolochia spp showed a certain toxicity to L-02 of normal hepatocytes.The results showed that the ethyl acetate extract and the ethyl acetate extract from blue blue blue had significant anti-hepatoma activity in the further test of anti-hepatoma activity of HepG2.Both of them showed a significant time-dependent and dose-response relationship in anti HepG2 hepatoma cell line activity.The morphology of HepG2 cells treated with ethyl acetate extract from blue sparrow flower or ethyl acetate extract from blue blue blue was observed by inverted microscope and Hoechst 33258 fluorescence staining.The results suggested that the ethyl acetate extracts from the blue sparrow and the blue blue blue may have anticancer activity by inducing apoptosis of HepG2 cells.
【作者单位】: 中南民族大学药学院;华中科技大学同济医学院附属同济医院药学部;青海民族大学科学科技处;
【基金】:国家自然科学基金项目(81573561) 青海省自然科学基金项目(2012-Z-904)
【分类号】:R29

【相似文献】

相关期刊论文 前9条

1 玛依努尔·艾力;哈木拉提·吾甫尔;;维吾尔药异常黑胆质成熟剂总黄酮逆转肝癌细胞耐药性的作用[J];中国中医药信息杂志;2007年09期

2 燕忠生,李金田,何大伟;三氧化二砷抗肝癌理论与临床研究评析[J];中医药学刊;2003年07期

3 祝金泉,黄德强,张q和,陈江,胡伟,谢勇,吕农华,王崇文;野桃树根对肝癌细胞毒作用的实验研究[J];江西医学院学报;2001年04期

4 孙艳,官杰,王琪;冬虫夏草对H_(22)肝癌小鼠化疗后免疫功能的影响[J];中国基层医药;2002年02期

5 王雅楠;曹蕊;朱聪;吴雄志;;夏枯草硫酸多糖对肝癌血管生成的作用及机制研究[J];中国肿瘤临床;2014年12期

6 李穗晖;吴建奇;陈瑶;陈燕;周岱翰;;参桃软肝丸对H_(22)肝癌荷瘤小鼠端粒酶活性及CD4~+CD25~+调节性T细胞比例的影响[J];中医药导报;2014年02期

7 卢文丽;方肇勤;潘志强;梁超;管冬元;吴中华;刘小美;;同病异证H22肝癌小鼠甲状腺机能及激素合成关键基因表达特征[J];中西医结合肝病杂志;2011年06期

8 钟鸣;余胜民;郑作文;邹静;张文涛;;壮药“复方铁草胶囊”抗肿瘤作用的实验研究[J];广西中医药;2010年02期

9 ;[J];;年期

相关重要报纸文章 前1条

1 张中桥;AFP可作为治疗肝癌的新靶标[N];中国医药报;2006年



本文编号:1739140

资料下载
论文发表

本文链接:https://www.wllwen.com/zhongyixuelunwen/1739140.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户fd10c***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com